Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 versus free combination versus beclometasone monotherapy in partly controlled pediatric asthma
2009-016757-18Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate, formoterol and beclometasone dipropionate + formoterol in asthma and persistent asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Change from baseline to Week 12 in pre-dose morning FEV1. Started Jun 2011; status: completed.
02
Drugs
beclomethasone dipropionateformoterolbeclometasone dipropionate + formoterol
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2009-016757-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016757-18.